Dual Versus Single Antiplatelet Therapy (DAPT) Duration after Drug-Eluting Stent (DES) Placement in Patients with High Bleeding Risk
Fortune Journal of Health Sciences · 2026 · 9 (1)
DOI: 10.26502/fjhs.404 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fortune Journal of Health Sciences, 2026. Verfasst von Dina AlMistarihi und 13 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
AlMistarihi, D., Chavan, D. M., Rafique, S., Ebrahim, M., Sharin, S., Witry, R. M. A., Ali, E. E. M., Elsadig, A. I., Adam, Z. M. A., Alahmar, D. B. A., Ahmed, W. A. M., Namoora, Y. A. M., Ateeq, A. F. M., & Himmad, H. M. H. (2026). Dual Versus Single Antiplatelet Therapy (DAPT) Duration after Drug-Eluting Stent (DES) Placement in Patients with High Bleeding Risk. Fortune Journal of Health Sciences, 9(1). https://doi.org/10.26502/fjhs.404
Vancouver
AlMistarihi D, Chavan DM, Rafique S, Ebrahim M, Sharin S, Witry RMA, et al. Dual Versus Single Antiplatelet Therapy (DAPT) Duration after Drug-Eluting Stent (DES) Placement in Patients with High Bleeding Risk. Fortune Journal of Health Sciences. 2026;9(1). doi:10.26502/fjhs.404
BibTeX
@article{AlMistarihi2026,
author = {AlMistarihi, Dina and Chavan, Dr. Mugdha and Rafique, Sumaiya and Ebrahim, Muhammed and Sharin, Shaheeda and Witry, Rana Mustafa Al and Ali, Eman Elsayed Mohamed and Elsadig, Afnan Ibrahim and Adam, Zainab Mohammed Ali and Alahmar, Dania Babeker Ali and Ahmed, Walaa Abdalla Mohamed and Namoora, Yazan Ahmed Mahmood and Ateeq, Aateka Fatima Mohammed and Himmad, Huda Mohamed Hussein},
title = {Dual Versus Single Antiplatelet Therapy (DAPT) Duration after Drug-Eluting Stent (DES) Placement in Patients with High Bleeding Risk},
journal = {Fortune Journal of Health Sciences},
year = {2026},
volume = {9},
number = {1},
doi = {10.26502/fjhs.404}
}
EUVIMED